Literature DB >> 19807992

Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery.

Joshua Jervis-Bardy1, Andrew Foreman, John Field, Peter John Wormald.   

Abstract

BACKGROUND: Differentiating normal nasal discharge and postoperative crust from infection after endoscopic sinus surgery (ESS) can be difficult. We investigated whether bacteria cultured at operation was predictive for postoperative mucosal infection-defined as frank pus, thick mucus, and/or abnormal crusting seen on endoscopic examination associated with positive microbiology.
METHODS: The records of 48 patients with chronic rhinosinusitis (CRS) with infection at the time of ESS were retrospectively reviewed. Results of intraoperative cultures were compared with those taken at the time of postoperative mucosal infection.
RESULTS: Fourteen of 16 patients (87.5%) with intraoperative infection with Staphylococcus aureus progressed to postoperative mucosal infection with S. aureus, whereas patients who cultured "other" bacteria intraoperatively progressed to postoperative mucosal infection in 6/19 cases (31.6%), with S. aureus cultured in only 3/19 cases (15.8%; p=0.0001).
CONCLUSION: S. aureus infection at ESS predicts for abnormal, S. aureus-associated mucosal healing and infection post-ESS. Although a prospective trial is warranted, these findings suggest a future role for aggressive anti-S. aureus therapy peri- and/or postoperatively in patients who culture positive for this organism to improve postsurgical outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19807992     DOI: 10.2500/ajra.2009.23.3366

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  12 in total

1.  The impact of intraoperative saline irrigations on bacterial load within the maxillary sinus.

Authors:  Kristin A Seiberling; Richard K McHugh; Wilson Aruni; Christopher A Church
Journal:  Int Forum Allergy Rhinol       Date:  2011-06-14       Impact factor: 3.858

2.  [Postoperative treatment following paranasal sinus surgery].

Authors:  Thomas S Kühnel; Werner G Hosemann; Rainer Weber
Journal:  HNO       Date:  2021-05-03       Impact factor: 1.284

Review 3.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

4.  Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use.

Authors:  Manal A Aziz; Jaydee D Cabral; Heather J L Brooks; Stephen C Moratti; Lyall R Hanton
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

5.  Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis.

Authors:  Leah M Feazel; Charles E Robertson; Vijay R Ramakrishnan; Daniel N Frank
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

6.  Postoperative antibiotic use in patients with unilateral purulent chronic rhinosinusitis.

Authors:  Alex Gordon; Peter Benedict; Sonya Marcus; Matthew Kingery; Richard A Lebowitz; Seth M Lieberman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-07-22

7.  The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection.

Authors:  Sam Boase; Andrew Foreman; Edward Cleland; Lorwai Tan; Rachel Melton-Kreft; Harshita Pant; Fen Z Hu; Garth D Ehrlich; Peter-John Wormald
Journal:  BMC Infect Dis       Date:  2013-05-08       Impact factor: 3.090

8.  Inflammatory immune response in rabbits with Staphylococcus aureus biofilm-associated sinusitis.

Authors:  Xianmin Wu; Yue Zhang; Xiaoyun Chen; Jun Chen; Minghui Jia
Journal:  Int Forum Allergy Rhinol       Date:  2018-07-06       Impact factor: 3.858

Review 9.  The microbiome of the upper respiratory tract in health and disease.

Authors:  Christina Kumpitsch; Kaisa Koskinen; Veronika Schöpf; Christine Moissl-Eichinger
Journal:  BMC Biol       Date:  2019-11-07       Impact factor: 7.431

10.  Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms.

Authors:  Camille Jardeleza; Shasha Rao; Benjamin Thierry; Pratik Gajjar; Sarah Vreugde; Clive A Prestidge; Peter-John Wormald
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.